Live Deals

Active Portfolio

Revolutionizing the way the world views science

Seed
Series A
Pre-B Bridge
  • $8.2 billion global market opportunity
  • Award-winning products with $22 million in sales
  • New products in R&D for advanced applications
Explore
Offered By: Bioverge Funds Management LLC

Removal of Toxic Protein Buildup to Treat ALS/Neurodegenerative Diseases

Seed
Series A
  • Potential to Slow/Halt Progression of ALS
  • Funding & Strategic Support from Amgen, Thiel,...
  • World-Class Team (Harvard, MIT, Medtronic, J&J,..)
Explore
Offered By: Bioverge Funds Management LLC

Personalized microbiome health services & data platform

Seed
  • Focus on clinical-grade data and quality control
  • $1M+ revenue, 15% monthly growth, 55% retention
  • Partnering with major Pharma/food/chem companies
Explore
Offered By: Bioverge Funds Management LLC

Changing the way cancer is treated

Seed
Series A
Pre-B
Series B
  • Platform identifies personalized drug combinations
  • Highly accurate drug response predictions
  • Multiple academic/pharma partnerships underway
Explore
Offered By: Bioverge Funds Management LLC

Wireless Electronics to Stimulate Surgical Healing of Bone

Seed
  • Stimulate/Adjust/Monitor Bone Growth in Real Time
  • Tackling an Annual $80B Problem in Orthopedics
  • SmartFuse: Heals Bone 4X Better, 2X Faster, Safer
Explore
Offered By: Bioverge Funds Management LLC

AI-driven, personalized nutrition platform

Seed
  • Curated, adaptive, on-demand meal guidance
  • 6 Acquisition offers; Partnership with Apple
  • $300B+ ‘Food as Medicine’ market
Explore
Offered By: Bioverge Funds Management LLC

Helping global populations live chronic disease-free

Seed
  • Digital diabetes prevention 2X effective as drugs
  • Reducing risk of Type-2 Diabetes by 60%
  • International partnership with Merck KGaA
Explore
Offered By: Bioverge Funds Management LLC

Crowdsourcing medical expertise

Seed
  • Solving elusive cases (avg: 6+ years, 8+ doctors)
  • 1M+ unique monthly visitors
  • 5-18X ROI for doctors/health plans/employers
Explore
Offered By: Bioverge Funds Management LLC

Early Diagnosis and Treatment of Alzheimer's Without Drugs

Seed
  • 250M Alzheimer's Patients thru 2050 = $5.4T Market
  • AD Drugs Failing in Humans; Only Treating Symptoms
  • Predict AD Risk, Prevent & Treat Underlying Cause
Explore
Offered By: Bioverge Funds Management LLC

AI-Powered Drug Discovery for Neurodegenerative Diseases

Seed
  • Leading edge biology combined w/ machine learning
  • Female Founder & CEO leads top-tier team
  • World-class research partnerships
Explore
Offered By: Bioverge Funds Management LLC

Enabling precision genetic medicine

Seed
Seed+
  • Universal delivery platform for gene therapies
  • Rapid, affordable, targeted to specific cell types
  • Disrupting $100B+ Hematology Market
Explore
Offered By: Bioverge Funds Management LLC

BV Showcase

Revolutionizing preclinical drug discovery research

  • 50% cost reductions, 70% efficiency improvements
  • Tier 1 paid clients: Novartis, Denali, Jackson Lab
  • Vetted, Awarded $1.85M in funding from NIH
Explore
Offered By: Bioverge Inc

Next-generation 3D bioprinting platform

  • Proprietary, light-based 3D bioprinting
  • 10x Speed and 5x Resolution
  • Most advanced engineered tissue ever
Explore
Offered By: Bioverge Inc

Mining the microbiome for novel therapeutic molecules

  • Computational drug discovery from within the body
  • Vast Data Engine: 10k patient samples, 38TB data
  • 2 Paid industry clients, 7 partner clinical orgs
Explore
Offered By: Bioverge Inc
The Bioverge platform is host to both Regulation Crowdfunding and Regulation D offering types. Reg CF offerings are provided by Bioverge Portal LLC and Reg D offering are provided by Bioverge Funds Management LLC. Companies designated as BV Showcase are enrolled in a program managed by Bioverge Inc and are not associated with an offering on the Bioverge platform.
Bioverge final lockup white
We use cookies to improve your experience on our site . By continuing to browse, you agree to our use of cookies, privacy policy , and terms of services.
I'm OK with that
I refuse cookies